Phase I study of PS-341 (bortezomib) with 5-fluorouracil/leucovorin (5-FU/LV) in advanced solid tumors: A California Cancer Consortium study.

被引：0
|
作者：
Iqbal, S
Cole, S
Yang, D
Lara, PN
Gumerlock, PH
Shibata, S
Synold, T
Doroshow, JH
Gandara, D
Lenz, HJ
机构：
[1] Univ So Calif, Los Angeles, CA USA
[2] Univ Calif Davis, Sacramento, CA USA
[3] City Hope Natl Med Ctr, Duarte, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2057
引用
收藏
页码：141S / 141S
页数：1
相关论文
共 50 条
  • [31] A phase I study of 5-fluorouracil, leucovorin and levamisole
    Cleary, JF
    Arzoomanian, R
    Alberti, D
    Feierabend, C
    Storer, B
    Witt, P
    Carbone, P
    Wilding, G
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1997, 39 (04) : 300 - 306
  • [32] Leucovorin, 5-fluorouracil, and gemcitabine: A phase I study
    Poplin, E
    Roberts, J
    Tombs, M
    Grant, S
    Rubin, E
    INVESTIGATIONAL NEW DRUGS, 1999, 17 (01) : 57 - 62
  • [33] A phase I study of 5-fluorouracil, leucovorin and levamisole
    J. F. Cleary
    Rhoda Arzoomanian
    Donna Alberti
    Chris Feierabend
    Barry Storer
    Pauline Witt
    P. P. Carbone
    George Wilding
    Cancer Chemotherapy and Pharmacology, 1997, 39 : 300 - 306
  • [34] Leucovorin, 5-fluorouracil, and gemcitabine: A phase I study
    Elizabeth Poplin
    John Roberts
    Marybeth Tombs
    Steven Grant
    Eric Rubin
    Investigational New Drugs, 1999, 17 : 57 - 61
  • [35] PHARMACOKINETICS OF A NOVEL FORMULATION OF 5-FLUOROURACIL (5FU) AND LEUCOVORIN (LV): (DEFLEXIFOL) IN A PHASE I TRIAL
    Ackland, Stephen
    Garg, Madhu
    Ranson, Marie
    Jokela, Rebecca
    Reynolds, Gemma
    De Souza, Paul
    Clingan, Philip
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2016, 12 : 21 - 22
  • [36] PHASE II STUDY OF DOCETAXEL AND 5-FLUOROURACIL (5-FU) WITH CONCURRENT RADIOTHERAPY IN PATIENTS WITH ADVANCED ESOPHAGEAL CANCER
    Hihara, J.
    Hamai, Y.
    Emi, M.
    Aoki, Y.
    Miyata, Y.
    Okada, M.
    ANNALS OF ONCOLOGY, 2010, 21 : 238 - 238
  • [37] Phase II randomized study of oral uracil/tegafur (UFT) plus leucovorin (LV) or parenteral 5-Fluorouracil (5-FU) plus leucovorin in patients with metastatic colorectal cancer (MCRC)
    Sizer, B.
    Makris, A.
    Barone, C.
    Bordonaro, R.
    Hausmaninger, H.
    Steger, G.
    Aloe, A.
    Peeters, O.
    Donato, B.
    ANNALS OF ONCOLOGY, 2004, 15 : 93 - 93
  • [38] A phase I study of vitamin E, 5-fluorouracil and leucovorin for advanced malignancies
    Blanke, CD
    Stipanov, M
    Morrow, J
    Rothenberg, M
    Chinery, R
    Shyr, Y
    Coffey, R
    Johnson, DH
    Leach, SD
    Beauchamp, RD
    INVESTIGATIONAL NEW DRUGS, 2001, 19 (01) : 21 - 27
  • [39] A Phase I Study of Vitamin E, 5-Fluorouracil and Leucovorin for Advanced Malignancies
    Charles D. Blanke
    Michael Stipanov
    Jason Morrow
    Mace Rothenberg
    Rebecca Chinery
    Yu Shyr
    Robert Coffey
    David H. Johnson
    Steven D. Leach
    R. Daniel Beauchamp
    Investigational New Drugs, 2001, 19 : 21 - 27
  • [40] FOLINIC ACID (FA) AND 5-FLUOROURACIL (5-FU) - PHASE-I-II STUDY
    CUNNINGHAM, JR
    BUKOWSKI, RM
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1983, 33 (02) : 221 - 221
12345